Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells

Translational Oncology(2023)10.1016/j.tranon.2023.101676Source: DataRank Database

G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells is a research paper published in Translational Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.30)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Emmanuel Bikorimana ORCID,Raya I. Boyd ORCID,Doha Shokry ORCID,Kelly Kries ORCID,Ayush Gupta ORCID

Live enrichment

PubMed:37086619 PMC:PMC10214302 OpenAlex:https://openalex.org/W4366494219

US Department of Defense

Grant: W81XWH2110903

National Institutes of Health

Grant: R01-CA211875

National Institutes of Health

Grant: R01CA234025

National Institutes of Health

Grant: R03CA223709

NCI NIH HHS

Grant: R01 CA211875

NIEHS NIH HHS

Grant: T32 ES007326

National Institutes of Health

Grant: 5R01CA234025-03

Impact of cholesterol and its metabolites on breast cancer progression

National Institutes of Health

Grant: 1R03CA223709-01A1

A Novel Clinically Relevant Tumor Suppressor in Human Breast Cancer

National Institutes of Health

Grant: 5R01CA211875-05

DNA Methylation Inhibitor Therapy for Testicular Cancer

FWCI

1.30

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.tranon.2023.101676

publisherhttps://doi.org/10.1016/j.tranon.2023.101676

publisherhttps://api.elsevier.com/content/article/PII:S1936523323000621?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1936523323000621?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37086619

Fields of Study

Lipid metabolism and biosynthesisGenomics and Chromatin DynamicsEstrogen and related hormone effects

Keywords

Adipose triglyceride lipaseEstrogen receptorCancer researchDownregulation and upregulationEstrogenEndocrinologyInternal medicineBiologyBreast cancerCell biologyChemistryAdipose tissueCancerLipolysisMedicineGeneEpithelial Mesenchymal TransitionAntiestrogenG0s2Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282Original Research

Sustainable Development Goals

SDG 0: No poverty

G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells

FAIR Checklist

Authors (13)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)